AN ADC SP INTENSIVE BB

Manufacturer
AN Co Ltd.
Effective date
2016-06-24
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-05-31 22:46:23

Label at a glance#

ProductAN ADC SP INTENSIVE BB
Active ingredientTitanium Dioxide
Label structure6 sections

Label contents#

Full prescribing information#

ACTIVE INGREDIENT

OTC - ACTIVE INGREDIENT SECTION

Active Ingredient: Titanium Dioxide 3.45%

INACTIVE INGREDIENT

INACTIVE INGREDIENT SECTION

Inactive Ingredients: Water, Caprylic/Capric Triglyceride, Glycerin, Iron Oxides/Triethoxycaprylylsilane, Propylene Glycol, Panthenol, Hectorite/PropyleneCarbonate /Quaternium-18, Squalane, Cetyl PEG/PPG-10/1 Dimethicone, Niacinamide, ButyleneGlycol Dicaprylate/Dicaprate, Portulaca Oleracea Extract, Ipomoea Purpurea Extract/Paeonia Albiflora Flower Extract/Magnolia Liliflora Flower Extract/Lilium Candidum Flower Extract, Aloe Barbadensis Leaf Extract, Sorbitan Sesquioleate, Magnesium Sulfate, Arbutin, CeramideNP/Hydrogenated Polydecene/Stearic Acid/ButyrospermumParkii(Shea) Butter/Ceteareth-20/Glyceryl Citrate/Lactate/Linoleate/Oleate Butylene glycol, Phenoxyethanol, Microcrystalline Wax, Beeswax, Dimethicone, Fragrance, Hydroxyethylcellulose, Tocopheryl Acetate, Copper Tripeptide-1, Palmitoyl Pentapeptide-4

PURPOSE

OTC - PURPOSE SECTION

Purpose: Sunscreen

WARNINGS

WARNINGS SECTION

Precautions on use: 1. Stop using the product if there are any of the following abnormal symptoms appearing after use and consult with your dermatologist as continued use can worsen the symptoms. A) If there are red spots, swelling, itchiness, or irritation B) If the above symptoms appear around the skin to which the product has been applied after being exposed to direct sunlight. 2. Precautions on storage and handling A) Make sure to close the cap after use. B) Keep out of the reach of children. C) Do not keep the product in a hot or cold place or a place getting direct sunlight. 3. Do not apply the product to any parts of the skin with wound, eczema, or dermatitis.

DESCRIPTION

DESCRIPTION SECTION

Suggested use: After the final stage of basic makeup, apply an appropriate amount of the BB cream to the whole face and gently massage the face upwards to help the skin absorb the nutrients.

Dosage & administration: Apply 2~3g of BB cream to face gently.

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Image of cartonImage of carton

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
69153-110-022023-01-30C16284748780-1f386c649-f585-0266-e053-dadaa90a7c1aa2595e72-58f2-4c94-8944-3354a9b2fbaf

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
69153-110-01AN ADC SP INTENSIVE BB50 g in 1 TUBECREAM501
69153-110-02AN ADC SP INTENSIVE BB1 in 1 CARTONCREAM11

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
69153-110AN ADC SP INTENSIVE BB (TITANIUM DIOXIDE) CREAM [AN CO LTD.]1Legacy NDC, 2 package rows20160624_a2595e72-58f2-4c94-8944-3354a9b2fbaf.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 4 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
69153-11069153-110-01, 69153-110-02

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 3 matching rows.

Name, UNII, Kind table
NameUNIIKind
Titanium Dioxide15FIX9V2JPACTIB
Water059QF0KO0RIACT
GlycerinPDC6A3C0OXIACT

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
ebae5e45-cea2-4506-9397-40641a6c45fda2595e72-58f2-4c94-8944-3354a9b2fbaf2016-06-24WarningsExact identifier
spl id: ebae5e45-cea2-4506-9397-40641a6c45fd
spl set id: a2595e72-58f2-4c94-8944-3354a9b2fbaf

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.